AMI ANEMIA MANAGEMENT INSTITUTE, created in 2004 (United States), from 142 sister brands and 17477 competing brands. AMI ANEMIA MANAGEMENT INSTITUTE is owned by Amgen, listed on the stock exchange of New York AMI ANEMIA MANAGEMENT INSTITUTE belongs to the Drug Manufacturers business sector.

AMI ANEMIA MANAGEMENT INSTITUTE is a brand of Amgen (AMGN) Share price

Share price and profitability of the share Amgen (AMI ANEMIA MANAGEMENT INSTITUTE)

Buy Amgen share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 284.26

Portfolio valuation
Amgen (AMI ANEMIA MANAGEMENT INSTITUTE) over 5 years* USD 421.35

Stock market history Amgen (AMI ANEMIA MANAGEMENT INSTITUTE)